Contact Us

TOURISM NEWS

Bambusa Therapeutics Announces First Subject Dosed in Phase 1 Clinical Trial of BBT001, a Novel Multi-Targeting, Half-Life Extended Bispecific Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Skin Diseases

Mar 3, 2025

Preclinical data with BBT001 demonstrate its best-in-disease potential for improved efficacy and dosing convenience compared to approved biologics in atopic dermatitis

SEMI Cybersecurity Consortium's NIST Semiconductor Manufacturing Community Profile Opens for Public Feedback

Mar 3, 2025

MILPITAS,Calif.,Feb. 28,2025--The SEMI Semiconductor Manufacturing Cybersecurity Consortium (SMCC),in partnership with the National Institute of Standards and Technology (NIST),advanced a semiconduct

MinIO Grows ARR by 149% as Demand for AI Data Storage Skyrockets

Mar 3, 2025

Solidifies position as object storage of choice for AI amidst the rise of Agentic AI and the "great race" of AI model performance

Great Tea Road Retracing: A Journey Along the Ancient Tea Trade Route

Mar 3, 2025

WUHAN,China,Feb. 28,2025-- The documentary seriesGreat Tea Road Retracing is produced by Hubei Daily Net. In the series,American tea enthusiast Hannah Carter takes viewers on an exploration along the

Blokees exhibits at the 2025 Toy Fair New York: World Premieres of New IPs Products on Minions

Mar 3, 2025

SHANGHAI,March 2,2025-- After its attendance at theSpielwarenmesse International Toy Fair in Nuremberg,Germany this January,Blokees,a Chinese brand specializing in building block figure toys,made anot

Hospital Kuala Lumpur & Rare Disease Patient Organizations Nationwide Celebrate Rare Disease Day 2025

Mar 3, 2025

KUALA LUMPUR,Malaysia,March 1,2025-- For the first time,Hospital Kuala Lumpur (HKL) is proudly hosting the annual Rare Disease Day 2025 celebration to raise awareness and advocate for individuals affe

1 ... 58 59 60 61 62 63 64 ... 332